IBI354 is an innovative HER2-targeted antibody–drug conjugate developed using Innovent's proprietary SoloTx® ADC platform.

As a company takes steps to transform the former Homer City Generating Station into what would be the largest natural ...

(9926.HK) ("Akeso" or the "Company") announced that at the 2025 ESMO Asia Congress, updated results from the pivotal Phase ...

Immatics reports promising anti-tumor activity and safety of IMA402 and IMA203CD8 in advanced cancers, supporting further development.

Inc., a private, US-based biopharmaceutical company committed to supporting the unique needs of patients with chronic ...

Moderna is rated a Hold, citing valuation concerns, lack of definitive long-term efficacy data, and significant execution and ...

Also, how you can help inform the next steps Missoula County takes to regulate data center development. The draft study of ...

Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a clinical-stage immunotherapy company targeting ...

Evaxion A/S announced promising three-year data from its phase 2 trial of the personalized cancer vaccine EVX-01 for patients ...

ImmVira Group ("ImmVira") today announced that updated clinical data from three bladder cancer studies of its lead oncolytic ...

Sleep quality affects cardiometabolic health in many ways, and it is important for healthcare professionals to routinely ask ...

What are we breathing? Please join Groundwork Hudson Valley in partnership with Air Partners at a public presentation of data ...